• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Cheng Tony Kin Shun converted options into 945 shares, covered exercise/tax liability with 841 shares and was granted 1,837 shares, increasing direct ownership by 10% to 22,079 units (SEC Form 4)

    1/22/24 3:39:41 PM ET
    $RGA
    Life Insurance
    Finance
    Get the next $RGA alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    CHENG TONY KIN SHUN

    (Last) (First) (Middle)
    16600 SWINGLEY RIDGE ROAD

    (Street)
    CHESTERFIELD MO 63017

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    REINSURANCE GROUP OF AMERICA INC [ RGA ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    President
    3. Date of Earliest Transaction (Month/Day/Year)
    01/18/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 01/18/2024 M 945(1) A (1) 21,083 D
    Common Stock 01/18/2024 F 305(2) D $168.31 20,778 D
    Common Stock 01/18/2024 A 1,837(3) A $168.31 22,615 D
    Common Stock 01/18/2024 F 536(2) D $168.31 22,079 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Share Unit - March 2021 $129.01(4) 01/18/2024 M 945 12/31/2023 (1) Common Stock 945 (1) 0 D
    Explanation of Responses:
    1. Restricted share units granted on March 11, 2021, fully vest on December 31, 2023.
    2. Shares of Common Stock delivered to Issuer as payment for taxes withheld. The reported share price $168.31, was the closing price on January 18, 2024, which was the price that was used for tax withholding purposes.
    3. Acquired pursuant to award of performance contingent stock granted in March 2021.
    4. Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
    Remarks:
    /s/ William L. Hutton, by Power of Attorney 01/22/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $RGA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RGA

    DatePrice TargetRatingAnalyst
    5/23/2025Strong Buy → Mkt Perform
    Raymond James
    4/2/2025$216.00Buy → Neutral
    UBS
    4/2/2025$237.00Neutral → Overweight
    Analyst
    10/9/2024$235.00Hold
    TD Cowen
    9/5/2024$255.00Overweight
    Barclays
    12/11/2023$171.00 → $189.00Hold → Buy
    Jefferies
    6/23/2023$170.00 → $160.00Buy → Hold
    Jefferies
    6/7/2023$199.00Strong Buy
    Raymond James
    More analyst ratings